USC Michelson Center welcomes Scripps Scientists Raymond C. Stevens, Peter Kuhn.

Scripps Research Institute scientists Raymond C. Stevens and Peter Kuhn, among the world’s most influential biomedical scientists in molecular research, are bringing their biomedical labs, including about 50 researchers, to the USC Michelson Center for Convergent Bioscience; the new health-science facility, which will house laboratories, a Center for Electron Microscopy and Analysis and microscopy imaging technology facilities, is being funded in part by a $50 million donation from retired surgeon Gary K. Michelson.

According to USC, Stevens and Kuhn will use the USC Michelson Center “to generate the bioscience discoveries that build a better, healthier future.” Their arrival enhances USC’s leadership in creating consequential research at the intersection of science and engineering.” says USC Provost Elizabeth Garrett.

Raymond C. Stevens, Ph.D.

Scripps | Scripps Scientist Raymond C. Stevens, Ph.D.
Scripps | Scripps Scientist Raymond C. Stevens, Ph.D.
Scripps | Scripps Scientist Raymond C. Stevens, Ph.D.
Scripps | Scripps Scientist Raymond C. Stevens, Ph.D.

Raymond C. Stevens, a pioneer into human cellular behavior research and the founder of four biotechnology companies and three National Institute of Health centers, has been involved in the creation of therapeutic molecules that led to breakthrough drugs aimed at curing influenza, childhood diseases, neuromuscular disorders or diabetes.

In addition of contributing to the area of high throughput structural biology and structure-based drug discovery, which fuses engineering breakthroughs with classical research techniques to answer vital questions about human cellular behavior, Stevens unlocked the structures of G protein-coupled receptors that serve as the cell’s gatekeepers and messengers. Their signals mediate nearly every essential physiological process — from immune system function to vision, taste and smell to cognition to heartbeat — and are essential for pharmaceutical drug development.

A prolific scholar, he has authored more than 300 peer-reviewed publications.

“We came to USC because of the opportunity to converge the sciences and dramatically increase our understanding of the structure and function of the human body at the atomic scale,” Stevens said.

Stevens joins USC after serving as professor of molecular biology and chemistry at The Scripps Research Institute. He is the founding director of the iHuman Institute at ShanghaiTech University in China, where he is helping to build scientific bridges across the Pacific Rim. Thomson Reuters named Stevens among “The World’s Most Influential Scientific Minds” for 2014.

“With the university’s leadership committed to convergence combined with key recruitment and connecting a number of outstanding researchers at USC in chemistry, biology, physics, math, medicine and engineering, we can make a really big impact in basic scientific discovery, translational science and education,” added Stevens, who also holds joint appointments in neurology, and physiology and biophysics at the Keck School of Medicine of USC.

Stevens earned his Ph.D. in chemistry from USC Dornsife, where he worked with Distinguished Professor of Chemistry and 1994 Nobel Prize winner George Andrew Olah and the late professor of chemistry Robert Bau. Stevens conducted postdoctoral research in structural biology at Harvard University with 1976 Nobel Prize winner William Lipscomb before joining the chemistry and neurobiology faculty at the University of California, Berkeley.

Peter Kuhn, Ph.D.

Scripps | Peter Kuhn, Ph.D.; Scripps Physics Oncology Center.
Scripps | Peter Kuhn, Ph.D.; Scripps Physics Oncology Center.
Scripps | Peter Kuhn, Ph.D.; Scripps Physics Oncology Center.
Scripps | Peter Kuhn, Ph.D.; Scripps Physics Oncology Center.

Peter Kuhn, formerly a physics professor at Stanford, co-leads one of the NIH Physical Sciences Oncology Centers, which is casting new light on how cancer spreads through the body. Partnering with oncologists and engineers, including faculty at the Keck School of Medicine and the USC Viterbi School of Engineering, Kuhn invented a method for detecting and characterizing cancer cells with a simple blood sample.

The minimally invasive, blood-based fluid biopsy test Kuhn developed differentiates circulating tumor cells from ordinary blood cells using a digital microscope and image-processing algorithm. The breakthrough holds the potential for identifying people at risk for other conditions as well, including a heart attack. He founded the company Epic Sciences to bring such precision diagnostic technology from the academic laboratory to the marketplace.

He also arrives from Scripps, where he established the translational science program. He previously served on the faculties of medicine and accelerator physics at Stanford University. As a scientist and entrepreneur, he has spent nearly two decades enabling and managing large-scale investigations that bring together interdisciplinary teams of physical, life and biomedical sciences researchers.

Of the opportunity to expand his research and ongoing collaborations now that he is at USC, Kuhn said, “USC unites the best of the best, who all align on the vision of improving human health with scientific breakthroughs and bring outstanding scientific competencies to the table to make this vision a reality.”

A physicist by training, Kuhn initially studied at the Julius Maximilians Universität in Würzburg, Germany, before receiving his master’s and Ph.D. in physics at the University at Albany in New York. He has published more than 180 peer scientific articles and filed 16 patents.

Charles McKenna, vice dean for natural sciences, noted that the recruitment of Stevens, Kuhn and their colleagues underscores USC Dornsife’s continued development of top programs in the sciences: “Ray’s brilliant research bridging chemistry and biology is creating a foundation for exciting new breakthroughs in understanding the human body and treating many diseases linked to human cell signaling,” McKenna said. “And Peter’s visionary work on the biology of cancer metastasis will place USC Dornsife at the center of an interdisciplinary research endeavor in the life, engineering and medical sciences with direct implications for human health.”

Raymond C. Stevens and Peter Kuhn have been named Provost Professor of Biological Sciences and Chemistry and Dean’s Professor of Biological Sciences, respectively. The announcements were made by Provost Elizabeth Garrett and USC Dornsife College of Letters, Arts and Sciences Dean Steve Kay.

“Ray Stevens and Peter Kuhn are among the world’s most influential biomedical scientists, whose research on molecular structures and processes have led to important advances in medical treatments and pharmaceutical drugs,” USC Provost Elizabeth Garrett announced. “Their arrival enhances USC’s leadership in creating consequential research at the intersection of science and engineering.”

Dean Steve Kay also lauded Stevens and Kuhn, noting that the addition of their research groups is a major advancement for USC’s ongoing focus on shifting the life sciences from the descriptive to the predictive: “The recruitment of this elite team of inventive scientists helps propel the university’s focus on convergent bioscience and moves the needle for the entire medical field,” Kay said.

“Ray Stevens and Peter Kuhn are among the world’s most influential biomedical scientists, whose research on molecular structures and processes have led to important advances in medical treatments and pharmaceutical drugs”, USC Provost Elizabeth Garrett.

Fresh Minds

Soon joining Stevens and Kuhn at USC as professor (research) of biological sciences is James Hicks, their collaborator from Cold Spring Harbor Laboratory (CSHL), as well as two other colleagues from Scripps — Vadim Cherezov as professor of chemistry and Vsevolod “Seva” Katritch as assistant professor of biological sciences.

Scripps | James Hicks
Scripps | James Hicks
Scripps | James Hicks
Scripps | James Hicks

A cancer genomicist, Hicks uses single cell genomics to characterize rare human cancer cells in blood and bone marrow of cancer patients. His important contributions to the methodologies required to understand the human response to cancer therapeutics involve highly innovative ways of using next-generation single cell sequencing to investigate the genetic basis of tumor heterogeneity. After beginning his academic career at CSHL and Scripps, Hicks spent 10 years in the biotechnology industry before returning to spend the last decade as a research professor at CSHL, along with serving as a board member at several biotech companies. He received his Ph.D. in molecular biology and genetics from the University of Oregon’s Institute of Molecular Biology and has published more than 100 research papers and seven patent filings.

Scripps | Vadim Cherezov
Scripps | Vadim Cherezov
Scripps | Vadim Cherezov
Scripps | Vadim Cherezov

Cherezov is a structural biophysicist whose work sheds light on the structure, stability and function of biological membranes. He has developed numerous novel instruments and technologies to enhance the biophysical characterization and crystallization of membrane proteins. His efforts are leading to ever-better ways of observing changes in proteins as they occur, and he leads an international, interdisciplinary collaboration in this area. Cherezov has published more than 90 research papers and filed five patent applications. He earned his Ph.D. in biophysics from the Moscow Institute of Physics and Technology.

Scripps | Vsevolod 'Seva' Katritch
Scripps | Vsevolod 'Seva' Katritch
Scripps | Vsevolod 'Seva' Katritch
Scripps | Vsevolod 'Seva' Katritch

Katritch is a computational biologist who develops and applies computational tools to the study of key biological phenomena, from chromatin folding to the molecular basis of signaling via membrane receptors. He works with crystallographers, biophysicists, molecular biologists and medicinal chemists at a number of institutions to unlock these proteins’ full potential as drug targets. Katritch completed his Ph.D. in biophysics and molecular biology at the Moscow Institute of Physics and Technology.

“The work of Stevens, Kuhn, Hicks, Cherezov, Katritch and their laboratories will open new avenues of discovery in basic science, novel educational approaches, and drug therapies and cures,” Kay said. “USC is honored to be their home, their headquarters and their partner in supporting future breakthroughs that enhance our understanding of the human body and that lead to dramatic improvements in health.”

MMRF Initiative Page

Related Links

The Michelson Medical Research Foundation is a proud supporter of the University of Southern California and the USC Michelson Center for Convergent Bioscience thanks to the generous support of Dr. Gary K. Michelson and his wife, Alya Michelson.

The Michelson Medical Research Foundation is a proud supporter of the University of Southern California and the USC Michelson Center for Convergent Bioscience thanks to the generous support of Dr. Gary K. Michelson and his wife, Alya Michelson.

The Michelson Medical Research Foundation is a proud supporter of the University of Southern California and the USC Michelson Center for Convergent Bioscience thanks to the generous support of Dr. Gary K. Michelson and his wife, Alya Michelson.

The Michelson Medical Research Foundation is a proud supporter of the University of Southern California and the USC Michelson Center for Convergent Bioscience thanks to the generous support of Dr. Gary K. Michelson and his wife, Alya Michelson.